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SELF-EXPANDING METAL STENTS FOR 
PALLIATION OF OESOPHAGEAL CANCER –  
A 4-YEAR REVIEW
Morganayagi Govender1,2, Lucien Ferndale1,2, Sandie Thomson1,3
1Pietermaritzburg Metropolitan Hospitals – Department of Surgery, Grey’s Hospital, 
KZN; 2Nelson Mandela School of Medicine, University of KwaZulu-Natal; 3University 
of Cape Town; Surgical Research Society
Background: Endoscopic placement of self-expanding metal stents 
(SEMS) is widely used for palliation of dysphagia in patients with 
inoperable malignant oesophageal lesions. This study was undertaken 
to document the periprocedural experience with a pure endoscopic 
placement technique.
Patients and methods: Retrospective analysis of all patients stented for 
oesophageal cancer at the GI Unit at Grey’s Hospital, Pietermaritzburg, 
over a 4-year period (2007 - 2010). Data were analysed from 
completed procedure forms and included demographics, tumour 
length, the presence of fistulas, stent size and complications. Stenting 
was performed without radiological guidance. At endoscopy the 
oesophageal lesion was dilated over a guidewire, the stent passed over 
the wire and positioned and deployed under direct endoscopic vision.
Results: A total of 394 stents were inserted over a 4-year period, 27 
for benign and 367 for malignant disease. There were 347 patients in 
the malignant group, 30 of whom required repeat stenting. Of the 347 
patients, 142 (40.9%) were female and 205 (59.1%) male. The mean 
age was 60 years (range 38 - 101). Of the patients 328 were black 
(94.5%), 15 white (4.2%) and 4 Indian (1.3%).
The reasons for palliative stenting were distributed as follows: age 
>70 – 67 patients; tumour length >8 m – 102; presence of tracheo-
oesophageal fistula – 23; unspecified – 142. There was also one 
patient who had metastases, another who refused surgery, and one 
stent for post-oesophagectomy leak.
Of those requiring repeat stenting, 8 had stent migration, 10 proximal 
tumour overgrowth, 10 distal tumour overgrowth, 1 a blocked stent 
and 1 a stricture. Only 3 complications were recorded (0.9%) – 2 
iatrogenic tracheo-oesophageal fistulas and 1 false tract created 
through a long lesion. All 3 were nevertheless successfully stented.
Conclusion: The number of patients seen with inoperable oesophageal 
cancer at Grey’s Hospital is sizeable. The average annual load of 
palliative stents is 90 patients. Pure endoscopic SEMS placement 
is a viable and safe option with a low periprocedural complication 
rate. It forms the core of palliative care for patients with dysphagia, 
with or without fistulas. Recurrent dysphagia can still be effectively 
managed by restenting. More detailed follow-up is required to assess 
the long-term efficacy of SEMS in our setting. A prospective analysis, 
including quality of life surveys, is planned.
OUTCOME OF ENDOTHERAPY IN BLEEDING 
PEPTIC ULCER PATIENTS AT GROOTE SCHUUR 
HOSPITAL
Dion Levin1, Gillian Watermeyer1, Eduan Deetlefs1, David Metz2, 
Sandie Thomson1
1University of Cape Town; 2University of Pennsylvania, USA
Introduction: Endotherapy is highly effective at controlling bleeding 
from peptic ulceration. 
Aims: To assess the efficacy of endoscopic intervention for high-
risk bleeding peptic ulcer disease and benchmark our surgical and 
mortality rates, for current and future comparison.
Methods: 227 patients with high-risk peptic ulcers underwent 
therapeutic intervention (adrenalin injection) between January 2004 
and December 2009 (median age 57 years (range 19 - 87); 60.4% 
males). 
Results: Primary endoscopic haemostasis failed in 51/227 patients 
(22.5%); 8 patients underwent surgery, of whom 1 died; 5 patients 
were deemed unfit or died prior to further intervention; 38 patients 
underwent second endoscopic endotherapy, and 10 of these 
underwent surgery, of whom 3 died; 24 patients had successful 
second endotherapy; and 18/227 patients (7.9%) required surgery 
for bleeding not controlled at initial (44.4%) or second endoscopy 
(56.6%). Surgical patients had a higher Forrest classification (odds 
ratio (OR) 0.4 (2a/2b v. 1a/1b), p=0.01) and required more blood (OR 
1.4, p=0.0001), but demonstrated no difference in mortality. Overall 
30 patients (13.2%) died, 5.3% by day 3 and 7.9% by day 30; 4 patients 
died after surgery, 2 by day 3 and 2 by day 30; and 16 patients, all 
of whom had significant co-morbid medical conditions, died after 
successful primary endotherapy. Rebleeding was the only predictor of 
death in patients who died at day 3 (OR 14.9, 95% confidence interval 
(CI) 2.6 - 83.4). A high Rockall score was the only predictor of death 
at day 30 (OR 2.09, 95% CI 1.3 - 3.17). 
Conclusion: Our overall benchmark mortality is 13.2% and surgical 
mortality 22%. More than half of the patients who died did so 
as a result of medical co-morbidity, despite successful primary 
endotherapy. Our rate of failed primary endoscopic haemostasis 
is 22.5%. Rebleeding after primary endoscopic intervention is a 
predictor of death at day 3. This study supports the use of the Rockall 
score to predict mortality at day 30.
AMYLASE AND ALANINE TRANSAMINASE 
LEVELS AS DISCRIMINATORS OF AETIOLOGY 
IN AN URBAN SOUTH AFRICAN POPULATION 
WITH ACUTE PANCREATITIS
Zaheer Moolla, Frank Anderson, Sandie Thomson
University of KwaZulu-Natal, Durban 
Introduction: In acute pancreatitis (AP), serum elevations of amylase 
and alanine transaminase (ALT) have been shown in Western series 
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to be predictive of aetiology. We analysed these predictors in the 
context of a South African cohort which includes antiretroviral 
therapy and hypertriglyceridaemia.
Materials and methods: A prospectively collected database of 386 
AP patients admitted to Addington Hospital, Durban, between 2001 
and 2008, was analysed. The relationship between admission amylase 
or ALT and aetiology based on history, abdominal ultrasound and 
serum triglycerides was studied: 238 patients (17 females) were 
admitted with acute alcoholic pancreatitis (AAP), 76 (21 males) with 
acute gallstone pancreatitis (GSAP), 42 (15 males) with pancreatitis 
secondary to antiretroviral therapy (ARVAP) and 30 (4 males) with 
AP due to hypertriglyceridaemia (HAP).
Results: The levels according to aetiology are set out in the table.
Amylases and ALT levels in GSAP were significantly higher than 
those for all other aetiologies and were similar for non-biliary causes. 
An ALT level of >56 U/l had a sensitivity of 71%, a specificity of 80% 
and a negative predictive value of 91% for gallstones.
Conclusion: GSAP average amylases were double those for other 
aetiologies. A normal ALT was highly predictive of non-gallstone 
aetiology. Neither amylase nor ALT could help differentiate 
the other aetiologies.
COX-2 AND PPARG EXPRESSION IN 
COLORECTAL CANCER: A ROLE FOR 
INFLAMMATION?
Mary Ngaira, Ernst Fredericks, Gill Dealtry, Saartjie Roux
Nmmu, Port Elizabeth, South Africa
Background: In 2010 we showed that PPARg, a nuclear receptor 
involved in cell signalling and promoting normal differentiation, 
is 7.5-fold down-regulated in colorectal cancer (CRC) patients 
compared with normal. Inflammation and oxidative stress can 
modulate PPARg expression. Inflammation could therefore be one of 
the important causes of CRC as indicated by the higher incidence of 
CRC among inflammatory bowel disease (IBD) patients.
Aim: To investigate the role of COX-2 as a marker of inflammation 
in the pathogenesis of CRC.
Method: Colon biopsies of 99 patients in the following groups: control, 
IBD (Crohn’s and ulcerative colitis (UC) – inflammatory group) and 
irritable bowel syndrome (IBS) (diarrhoea (D) or constipation (C) 
predominant – non-inflammatory group). Immunohistochemical 
analysis was performed and compared with PPARg qPCR.
Results: A striking increase in COX-2 protein expression was 
observed in the lamina propria of CRC patients, as previously 
reported. In the IBD group, UC patients had higher total COX-2 
expression in both lamina propria and epithelial cells compared with 
Crohn’s disease patients, regardless of treatment. Surprisingly, D-IBS 
patients had significantly higher (p<0.01) COX-2 expression in the 
epithelial cells than the control group, unlike the C-IBS group. The 
reason for this is not clear.
Although the CRC patients had raised COX-2 expression in the 
epithelial cells as well as the lamina propria and low PPARg expression, 
a direct relationship between PPARg and COX-2 expression could 
not be established in the other colorectal pathologies investigated.
Conclusion: Our surprising observation of low COX-2 expression in 
IBD patients is supported by Vong et al., 2010. This partially explains 
the exacerbation of IBD when treated with COX-2 inhibitors. The 
pathogenesis of CRC is not necessarily COX-2 driven, but may 
involve other cytokines. It is clear that more research is needed on 
the regulation of the different cytokines and homeostatic control of 
the colon environment.
IDENTIFYING FAMILIES WITH LYNCH 
SYNDROME IN SOUTH AFRICA
S Macaulay, J F Botha, A Krause
1National Laboratory Service, Johannesburg; 2University of the Witwatersrand, 
Johannesburg;  3Sandton Medi-Clinic, Johannesburg
Background: Lynch syndrome (hereditary non-polyposis colorectal 
cancer (HNPCC)) is an autosomal dominant condition predisposing 
individuals to the development of colorectal and endometrial cancers 
as well as stomach, hepatobiliary, small-bowel and central nervous 
system cancers. Lynch syndrome occurs as a result of mutations in 
one of four main genes (MLH1, MSH2, MSH6 and PMS2) involved 
in the DNA mismatch repair pathway.
Aim: The study aimed to highlight the necessary steps clinicians 
and genetic counsellors need to take in order to assess the likelihood 
and then confirm a diagnosis of Lynch syndrome. We present cases 
of South African Caucasian families in whom a diagnosis of Lynch 
syndrome was suspected.
Methods: Baseline analysis involved drawing the family pedigree. On 
the basis of the family history alone it can be determined whether or 
not a family is at high risk for a genetic cancer syndrome.
Secondly, immunohistochemistry (IHC) analysis on histology blocks 
was performed. In an ideal situation, microsatellite instability analysis 
should also be performed; however, this is not available in South 
Africa, so IHC in conjunction with pedigree analysis is relied upon. 
IHC has its own limitations and the interpretation of results requires 
technical expertise.
Thirdly, diagnostic genetic testing was performed on patients’ DNA 
once the work-up suggested a likely diagnosis of Lynch syndrome.
Results: In one family a novel MSH2 mutation was identified (c. 
1811C>A). Extensive IHC and genetic testing was required in order 
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Conclusion: Genetic counselling is important in baseline pedigree 
ascertainment and risk assessment. It also serves an important role 
in educating and informing such families about the condition and 
providing options for genetic testing and management. These cases 
illustrate the complex process of confirming and managing Lynch 
syndrome in South African families.
CASE REPORT: UPPER GASTRO-INTESTINAL 
KAPOSI’S SARCOMA IN AN HIV-POSITIVE 
PATIENT WITHOUT CUTANEOUS DISEASE AS A 
CAUSE FOR ANAEMIA AND ABDOMINAL PAIN
Nazeer Ahmed Chopdat, Reidwaan Ally
African Institute of Digestive Disease, Soweto, Johannesburg
Background: In June 2010 a 31-year-old woman was referred to 
our outpatient clinic. She had been diagnosed with HIV 1 month 
before her referral. She complained of constant abdominal pain, and 
difficulty and pain on swallowing. She had lost 10 kg over the past 
month. On physical examination she was wasted, pale and weak. She 
had generalised lymphadenopathy and oral thrush. No evidence of 
cutaneous karposis sarcoma lesions was seen.
Investigation and management: Laboratory investigations revealed 
an albumin level of 11 g/l, a haemoglobin concentration of 7.8 g/
dl and a normal mean cell volume of 85 fl. The CD4 count was 95 
cells/µl. The patient underwent oesophago-gastro-duodenoscopy 
which revealed oesophageal candidiasis and multiple plaque-like 
lesions. Histological examination and immunohistochemistry of the 
biopsy specimens were consistent with Kaposi’s sarcoma, positive 
nuclear staining for HHV 8 and Helicobacter pylori-associated 
chronic gastritis. The patient was started on eradication therapy, 
referred for highly active antiretroviral therapy (HAART) and sent 
to a specialised oncology unit to commence chemotherapy. She was, 
however, lost to follow-up.
Discussion: Infection with HIV results in a wide range of 
opportunistic infections and tumours, commonest of which is 
Kaposi’s sarcoma. Gastro-intestinal Kaposi’s sarcoma is usually most 
common in patients with extensive cutaneous disease; however, 
mucosal involvement without cutaneous involvement, though rare, 
has been described. We might well have attributed our patient’s 
symptoms to candidiasis, and had we not performed endoscopy we 
would have failed to diagnose the gastro-intestinal Kaposi’s sarcoma.
Conclusion: Biopsy of all suspicious lesions is necessary in HIV-
positive patients. Early diagnosis of gastro-intestinal Kaposi’s 
sarcoma is desirable from prognostic and therapeutic points of view. 
Symptoms may resolve and progression of disease be delayed with 
HAART and chemotherapy.
We therefore recommend early endoscopy in all patients with HIV 
who have persistent upper gastro-intestinal symptoms.
DIETARY INTAKE AND TOTAL DIETARY FIBRE 
INTAKE IN PATIENTS WITH IRRITABLE BOWEL 
SYNDROME
C Stevenson, E Fredericks, R Theunissen, G Dealtry, S Roux
Nelson Mandela Metropolitan University, Port Elizabeth, E Cape
Introduction: In the USA and the European Union, adult dietary 
fibre intake falls well below the recommended range of 20 - 35 g per 
day. Poor fibre intake is reflected in altered gut microbiota and short-
chain fatty acid production.
Aim: To assess the dietary intake of patients with irritable bowel 
syndrome (IBS) and compare this with healthy controls and 
international recommendations (dietary reference intakes, DRIs).
Methods: Three-day estimated food records were obtained from 26 
C-IBS, 10 D-IBS and 21 controls.
Results: Total energy intake and macronutrient distribution did 
not differ significantly between the groups. Total protein and 
carbohydrate consumption was higher than the recommended DRIs 
in all three groups. Fat intake was higher than the acceptable DRI 
range of 20 - 35% for the D-IBS group (D-IBS 37.59%, C-IBS 
35.26%, controls 33.46%). Total dietary fibre intake did not reach 
the recommended intake for all three groups, but was higher in the 
control group than both the C-IBS and D-IBS groups (D-IBS 13.64 
g, C-IBS 14.59 g, controls 16.73 g, p=0.363). Intakes of insoluble and 
soluble dietary fibre were low in all three groups, but the controls had 
a better intake than either of the IBS groups (insoluble fibre D-IBS 
3.68 g, C-IBS 3.48 g and controls 5.01 g, p=0.126; soluble fibre D-IBS 
2.66 g, C-IBS 2.71 g and controls 3.83 g, p=0.111). The D-IBS group 
had a statistically significant lower intake of vitamin A compared 
with the C-IBS and control groups (D-IBS 411.80 RE, C-IBS 695.76 
RE, controls 893.97 RE, p=0.06) and significantly lower intakes of 
total carotenoids, A-carotene and B-carotene.
Conclusion: This study highlighted that IBS patients did not meet 
recommendations for fibre intake and that intake was poor. The 
D-IBS group had an insufficient intake of vitamin A and carotenoids. 
This is similar to the findings of Aller et al. (2004), and warrants 
further research.
OVER-THE-COUNTER SALE OF NON-STEROIDAL 
ANTI-INFLAMMATORY DRUGS SHOULD BE 
BANNED!
Theshni Govender, Martin Brand
University of the Witwatersrand, Johannesburg
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are 
known for their complications. The US FDA issued a ruling in 2009 
that made it compulsory to list the gastro-intestinal and cardiac side-
effects of NSAIDs on all NSAID packaging. Large proportions of 
patients admitted to our hospital with upper gastro-intestinal (GIT) 
complaints are users of NSAIDs, and appear to be unaware of their 
significant side-effects. It is of concern that in South Africa NSAID 
preparations are freely available over the counter.
Methods: We performed a retrospective study from 1 January 
2010 to 31 December 2010 at Charlotte Maxeke Johannesburg 
Academic Hospital (CMJAH). All patients who were admitted with 
an upper GIT complaint, and subsequently underwent oesophago-
gastro-duodenoscopy or a surgical procedure and who did not 
have portal hypertension, were included. We used a university-
associated hospital’s cost structure, including hospital and doctors’ 
fees, to calculate the cost of these NSAID-associated upper GIT 
complications.
Results: In 2010, 163 patients were admitted with epigastric pain, 
upper GIT haemorrhage or perforation. Of 94 patient files collected 
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to date, 36 confirmed NSAID use. Of these patients, 4 underwent 
laparotomy.
Each of such admissions cost R20 520, which included only the 
following: 4 days in a general ward, consultation fees and oesophago-
gastro-duodenoscopy, and excluded intensive care unit admission and 
blood products. Each patient who required a laparotomy accrued a cost 
of R88 800. The estimated cost for these 36 patients was R1 093 920.
Conclusion: The cost to the CMJAH associated with NSAID use is 
substantial. This may be minimised by making NSAIDs available on 
prescription only.
QUESTRAN COLONIC CRYSTAL: BYSTANDER  
OR OFFENDER?
Kgaogelo Moeng1,2, Adam Mahomed1,2
1University of the Witwatersrand, Johannesburg; 2Charlotte Maxeke Johannesburg 
Academic Hospital, Johannesburg
Aim: To report on a rare but previously described gastro-
intestinal complication of a commonly used anion exchange resin, 
cholestyramine, and to explore the possibility of this agent’s being a 
cause of mucosal lesions.
Case summary: A 32-year-old immunocompromised patient was 
found to have colonic mucosal crystal deposits on histopathological 
specimens while being investigated for chronic diarrhoea. The 
mucosal biopsies were obtained after the patient had been treated 
with Questran 4 g 3 times a day for 6½ days. Endoscopy revealed 
associated fungating, ulcerating lesions with necrotic areas. An 
additional diagnosis of MTB was made from specimens obtained.
Discussion: Ion exchange resins are commonly used in clinical 
practice, with not many reported complications. Kayexalate and 
kalimate, the cation exchange resins used to treat hyperkalaemia, 
and cholestyramine (Questran), a bile-acid-binding anion exchange 
resin, have all been previously described as potential causes of gastro-
intestinal mucosal crystal deposits. While kayexalate and kalimate 
have both been found to cause mucosal ulceration, haemorrhage 
and necrosis, there is a paucity of information regarding such lesions 
in relation to cholestyramine. Our patients had tuberculosis of the 
colon, which could have been the cause of the ulcerating lesions 
found at endoscopy.
Conclusion: Ion exchange resins can cause gastro-intestinal mucosal 
crystal deposition in some patients. It is, however, not clear whether 
cholestyramine causes mucosal lesions in addition to crystal 
deposition. Our patient had MTB, which could potentially have 
caused the mucosal lesions.
JAUNDICE AS AN UNUSUAL PRESENTATION OF 
HODGKIN’S LYMPHOMA IN A PATIENT WITH 
TUBERCULOSIS
Mfanufikile Nomvete1,2, Keith Newton1,2, VG Naidoo1,2, Sadia Saeed2
1University of KwaZulu-Natal, Durban; 2Inkosi Albert Luthuli Central Hospital, Durban
Introduction: Cholestatic jaundice is a rare paraneoplastic 
complication of Hodgkin’s lymphoma.
Case: A 36-year-old black man was started on antituberculosis (TB) 
therapy at a peripheral hospital on an unclear basis. Cholestatic 
jaundice preceded the commencement of the anti-TB treatment 
and persisted despite discontinuation of the therapy. He had no 
risk factors for chronic liver disease, and presented with pruritus, 
dark urine and normal stools. Physical examination revealed deep 
jaundice, pallor, cervical lymphadenopathy, 4 cm hepatomegaly and 
2 cm splenomegaly. Laboratory results showed a total bilirubin level 
of 384.5 µmol/l (conjugated 276.7 µmol/l), alkaline phosphatase 681 
U/l, gamma-glutamyl transferase 107 U/l, and alanine transferase 130 
U/l. A chest radiograph was normal and an abdominal ultrasound 
scan confirmed hepatosplenomegaly and displayed no features of 
biliary obstruction or lymphadenopathy. A magnetic resonance 
cholangiopancreatogram was equivocal and an endoscopic retrograde 
cholangiopancreatogram revealed no biliary obstruction. Sputa were 
positive for acid-fast bacilli (AFB) and confirmed to be drug 
sensitive, so anti-TB treatment was re-instituted. A liver biopsy 
revealed homeostasis, no granulomas or AFB and no neoplastic 
infiltrate, and 6-week TB culture was negative. Hodgkin’s lymphoma 
(HL) was diagnosed on a lymph node biopsy and subsequent bone 
marrow biopsy. A staging computed tomography scan revealed intra-
abdominal lymphadenopathy, but none at the porta hepatis or peri-
pancreatic area. Following successful chemotherapy for the HL, the 
patient’s liver function test results normalised.
Discussion: Cholestatic jaundice is an uncommon presentation of 
HL. Mechanisms involved usually include hepatic tumour infiltration, 
portal tract destruction or biliary tree obstruction, or the condition 
is secondary to chemotherapy. Very rare is idiopathic cholestasis, 
which is thought to be mediated by inflammatory cytokines that alter 
the functioning of the bile salt exporter proteins. This paraneoplastic 
syndrome improves after treatment of the lymphoma.
Conclusion: Unexplained cholestasis should be carefully assessed to 
exclude an underlying potentially treatable systemic disorder.
MASSIVE AND MULTI-ORGAN INTRA-
ABDOMINAL HYDATID DISEASE: CASE REPORT
Orlando Zamora Santana
Nelson Mandela Academic Hospital, Mthatha, E Cape, and Enriquez Academic 
Hospital, Havana, Cuba
Hydatid disease is endemic in the Middle East as well as other parts 
of the world such as India, Africa, South America, New Zealand, 
Australia, Turkey and southern Europe. Hydatid cysts can occur 
in any organ, but infestation most commonly occurs in the liver, 
followed by the lung.
A 25-year-old man presented with a 3-year history of vague abdominal 
pain and progressive swelling of the abdomen. Clinical examination 
revealed non-tender firm masses in the abdomen. The liver was 
palpable, reaching about 10 cm below the costal margin. Rectal 
examination revealed globular masses in the pouch of Douglas.
We present the investigations done and our surgical findings and 
results.
It is important to emphasise that this disease should be suspected in 
patients with cystic lesions affecting any organ, especially in endemic 
areas of the world.
THE SPECTRUM OF THE OPERATIVE 
MANAGEMENT OF ACUTE APPENDICITIS AT A 
DISTRICT HOSPITAL
Muhammed Zaki Shaik, Sandie R Thomson
Nelson R Mandela School of Medicine and Addington Hospital, Durban
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276 April 2011, Vol. 101, No. 4  SAMJ
Background: In the era of the active adoption of laparoscopy, the 
spectrum of operative options employed in the management of 
suspected acute appendicitis in the state sector has not been well 
studied. We utilised a highly accurate prospective operative database 
to document and analyse current practice.
Methods: Data from the first 2 years were extracted and analysed 
from the Addington Hospital operative electronic database. 
Demographics, hospital stay, operative time, conversion rate, primary 
surgeon (registrar versus consultant), mortality and relaparotomy 
were extracted for the patients according to the surgical management 
(Lanz incision appendectomy, laparoscopic appendicectomy and 
laparotomy for complicated appendicitis). Statistical analysis was 
done using a two-sample t-test.
Results: There were a total of 322 operations for appendicitis from 
2009 to 2010.
In the laparotomy group, 3 patients had a right hemicolectomy. The rest 
were appendectomies with peritoneal toilet. Fifteen patients required 
relaparotomies, and 5 patients died. The age difference between the 
Lanz group and laparoscopic group was significant. Of the diagnostic 
laparoscopies for right iliac fossa pain, 63% (46/73) were diagnostic 
for appendicitis. The rest were diagnostic for pelvic inflammatory 
disease (PID). Eighteen operations were done by registrars. Five of the 
laparoscopic approaches were converted to laparotomy.
Conclusion: Advanced-stage appendicitis managed by laparotomy 
remains common, with associated morbidity and mortality. It results 
in double the hospital stay and an increased operating time when 
compared with the other two operative methods, for which hospital 
stay and operative times are similar. The utility of laparoscopy in 
differentiating acute appendicitis from PID is supported and is 
reflected in the increased female/male ratio in this treatment group.
CASE REPORT: THE CYSTIC SPLEEN –  
A DIAGNOSTIC DILEMMA
Mohamed Feroz Suliman, Nazeer A I Chopdat, Sunil Philip, 
Reid Ally
Chris Hani Baragwanath Hospital, Johannesburg, and African Institute of Digestive 
Diseases, Johannesburg
Background: In October 2010 a 45-year-old woman was referred to 
our hospital with a history of left upper quadrant pain and increasing 
swelling over the past 6 months. She denied any weight loss, night 
sweats or dyspeptic symptoms. She had a loss of appetite, intermittent 
nausea and vomiting but no diarrhoea. She had no previous medical, 
surgical or travel history. She denied any recent trauma, but on 
re-evaluation after obtaining her histology results we learned that 
she had been involved in a bomb explosion a few months previously 
while working in a laboratory. On physical examination she was 
found to be generally in good health. There was a mass in the left 
upper quadrant, with an asymmetrical abdomen.
Special investigations and management: An ultrasound scan 
revealed a large splenic cyst, and a computed tomography scan of the 
abdomen a 10×15×11 cm cystic lesion within the spleen.
Routine laboratory tests including hydatid serology were negative. 
The patient was taken to theatre for splenectomy. The rest of the 
abdomen was normal. Histological examination revealed a 10×15×11 
cm pseudocyst lined with fibrin and filled with fibrinous material. 
The remainder of the spleen measured 5×5×8 cm and contained 
smaller pseudocysts with fibrin. No granulomatous inflammation, 
neoplasia or echinococcus infection was identified.
Discussion: Pseudocysts of the spleen are classified as secondary 
cysts, which account for 70 - 80% of non-parasitic splenic cysts. 
They have thick collagenous walls with shaggy haemorrhagic centres 
containing brown/greenish-brown fluid. The risk of rupture increases 
with a size greater than 5 cm.
Conclusion: This case suggests that traumatic splenic injury should 
always be considered as a differential diagnosis in patients with large 
splenic cysts.
ABSTRACTS
Laparotomy Laparoscopic appendectomy Lanz appendectomy p-value
Proportion 40% (N=133) 14% (N=46)* 43.3% (N=143)
Mean age (yrs) (SD) 24 (15) 27 (13) 19 (10) <0.05
M/F ratio 1:1.4 1:2.4 2.8:1
Hospital stay (d) (SD) 7 (5.7) 4.3 (3.9) 3.7 (3.2) 0.5
Operative time (min) (SD) 73 (72) 61 (25) 53 (24) 0.053
*46 = total number of diagnostic laparoscopies for right iliac fossa pain (73) - number of patients with pelvic inflammatory disease (27).
